Contact
Please use this form to send email to PR contact of this press release:
Karolinska Development portfolio company Aprea Therapeutics updates clinical data from Phase Ib trial of APR-246 in ovarian cancer.
TO:
Please use this form to send email to PR contact of this press release:
Karolinska Development portfolio company Aprea Therapeutics updates clinical data from Phase Ib trial of APR-246 in ovarian cancer.
TO: